Discovery of Ecallantide: A potent and selective inhibitor of plasma kallikrein

被引：3
|
作者：
Ladner, R. [1 ]
Kent, R. [1 ]
Ley, A. [1 ]
Nixon, A. [1 ]
Sexton, D. [1 ]
机构：
[1] Dyax Corp, Cambridge, MA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 119卷 / 01期
关键词：
D O I：
10.1016/j.jaci.2006.12.591
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1218
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [31] Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
    Tao, Zhi-Fu
    Hasvold, Lisa
    Wang, Le
    Wang, Xilu
    Petros, Andrew M.
    Park, Chang H.
    Boghaert, Erwin R.
    Catron, Nathaniel D.
    Chen, Jun
    Colman, Peter M.
    Czabotar, Peter E.
    Deshayes, Kurt
    Fairbrother, Wayne J.
    Flygare, John A.
    Hymowitz, Sarah G.
    Jin, Sha
    Judge, Russell A.
    Koehler, Michael F. T.
    Kovar, Peter J.
    Lessene, Guillaume
    Mitten, Michael J.
    Ndubaku, Chudi O.
    Nimmer, Paul
    Purkey, Hans E.
    Oleksijew, Anatol
    Phillips, Darren C.
    Sleebs, Brad E.
    Smith, Brian J.
    Smith, Morey L.
    Tahir, Stephen K.
    Watson, Keith G.
    Xiao, Yu
    Xue, John
    Zhang, Haichao
    Zobel, Kerry
    Rosenberg, Saul H.
    Tse, Chris
    Leverson, Joel D.
    Elmore, Steven W.
    Souers, Andrew J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (10): : 1088 - 1093
  • [32] Discovery of potent and selective factor 11a arylpyrrolidine benzothiophene inhibitor
    Ogawa, Anthony
    VandeBunte, Ellen
    Lesburg, Charles
    Guo, Zhuyan
    Gao, Ying-Duo
    Mal, Rudrajit
    Moningka, Remond
    Romero, Anthony
    Anand, Rajan
    Colandrea, Vincent
    Geissler, Wayne
    Patel, Reshma
    Song, Xuelei
    Tschirret-Guth, Richard
    Hawes, Brian
    Wood, Blair
    Edmondson, Scott
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [33] Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
    Black, W. Cameron
    Abdoli, Abbas
    An, Xiuli
    Auger, Anick
    Beaulieu, Patrick
    Bernatchez, Michel
    Caron, Cathy
    Chefson, Amandine
    Crane, Sheldon
    Diallo, Mohamed
    Dorich, Stephane
    Fader, Lee D.
    Ferraro, Gino B.
    Fournier, Sara
    Gao, Qi
    Ginzburg, Yelena
    Hamel, Martine
    Han, Yongshuai
    Jones, Paul
    Lanoix, Stephanie
    Lacbay, Cyrus M.
    Leclaire, Marie-Eve
    Levy, Maayan
    Mamane, Yael
    Mulani, Amina
    Papp, Robert
    Pellerin, Charles
    Picard, Audrey
    Skeldon, Alexander
    Skorey, Kathryn
    Stocco, Rino
    St.-Onge, Miguel
    Truchon, Jean-Francois
    Truong, Vouy Linh
    Zimmermann, Michal
    Zinda, Michael
    Roulston, Anne
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (04) : 2349 - 2368
  • [34] Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter
    Gavrin, Lori K.
    Mahaney, Paige E.
    Jenkins, Douglas
    Nogle, Lisa M.
    Mugford, Cheryl A.
    Huselton, Christine
    Leiter, Jennifer
    Johnston, Grace H.
    Bray, Jenifer A.
    Burroughs, Kevin D.
    Cosmi, Scott A.
    Alfinito, Peter
    Ho, Douglas M.
    Deecher, Darlene C.
    Trybulski, Eugene J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (03): : 91 - 95
  • [35] A patient with hereditary angioedema who experienced anaphylaxis in response to C1 esterase inhibitor is successfully treated with DX-88 (Ecallantide1), a potent human plasma kallikrein inhibitor:: A case study
    Cicardi, Marco
    Zingale, Lorenza C.
    Zanichelli, Andrea
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 160 - 161
  • [36] Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors
    Li, Zhe
    Partridge, James
    Silva-Garcia, Abel
    Rademacher, Peter
    Betz, Andreas
    Xu, Qing
    Sham, Hing
    Hu, Yunjin
    Shan, Yuqing
    Liu, Bin
    Zhang, Ying
    Shi, Haijuan
    Xu, Qiong
    Ma, Xubo
    Zhang, Li
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (02): : 185 - 190
  • [37] Selective inhibitors of plasma kallikrein
    Evans, DM
    Jones, DM
    Pitt, GR
    SueirasDiaz, J
    Horton, J
    Ashworth, D
    Olsson, H
    Szelke, M
    IMMUNOPHARMACOLOGY, 1996, 32 (1-3): : 115 - 116
  • [38] Ecallantide (DX-88), a plasma kallikrein inhibitor for the treatment of hereditary angioedema and the prevention of blood loss in on-pump cardiothoracic surgery
    Lehmann, Andreas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (08) : 1187 - 1199
  • [39] Dose response in intravenous and subcutaneous administration of ecallantide, a potent inhibitor of human plasma kallikreinin, in patients with hereditary angioedema.
    Li, H.
    Lumry, W.
    Craig, T.
    Wilkinson, R.
    Schmalbach, T.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2007, 98 (01) : A30 - A30
  • [40] Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat
    Stadnicki, A
    DeLaCadena, RA
    Sartor, RB
    Bender, D
    Kettner, CA
    Rath, HC
    Adam, A
    Colman, RW
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (05) : 912 - 920
12345